The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

"Patients with anti-AQP4-Ab may basically need long-term relapse prevention, because they surely experience much higher relapse activity, with much worse neurological disturbance…In MOGAD patients, ...

Please provide your email address to receive an email when new articles are posted on . Being male or aged older than 40 years were consistently associated with poorer acute optic neuritis outcomes.

Please provide your email address to receive an email when new articles are posted on . Virtual reality headsets are portable and easy to use and have reasonable pricing. These headsets are ...

Dr. Bart K. Chwalisz: A 30-year-old woman was evaluated in the neuro-ophthalmology clinic at a hospital affiliated with this hospital because of monocular vision loss. Two months before the current ...